-
Hyperbaric Oxygen Therapy for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Case Report
-
Kwang Jin Kim, Yoonsuk Lee, Yong Sung Cha, Tae Wook Kang, Hyun Chul Chung, Hong Chung, Hyun Kim, Jae Hung Jung
-
Urogenit Tract Infect 2024;19(2):44-47. Published online August 31, 2024
-
DOI: https://doi.org/10.14777/uti.2024.19.2.44
-
-
 Abstract
 PDF PubReader ePub
- Hyperbaric oxygen therapy (HBOT) was conducted on two male patients with chronic prostatitis/chronic pelvic pain syndrome who were resistant to conventional medical therapies. Both patients underwent 20 sessions of 100% oxygen inhalation (2.0 atmosphere absolute for 90 min/day, five days/week for four weeks) in a hyperbaric chamber. The follow-up period was three months. Although the patients reported a slight improvement in the pain domain of the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) after HBOT, no changes were noted in the other domains of NIH-CPSI and International Prostate Symptom Score. No adverse events were encountered during or after HBOT.
-
Clinical Significance of National Institutes of Health-Chronic Prostatitis Symptom Index Pain Score in Patients with Benign Prostatic Hyperplasia
-
Chang Min Lee, Jae Mann Song, Kwang Jin Kim, Tae Wook Kang, Seung Hoon Ryang, Yun Byung Chae, Hyun Chul Chung, Jae Hung Jung
-
Urogenit Tract Infect 2015;10(2):102-107. Published online October 31, 2015
-
-
-
Abstract
PDF
- Purpose: Many benign prostatic hyperplasia (BPH) patients were accompanied by pelvic pain apart from urinary symptoms. Therefore, we evaluate the treatment outcomes of alpha-blockers via a change of international prostate symptom score (IPSS) according to pain score of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).
Materials and Methods: A total of 356 male patients with BPH from March 2011 to May 2014 were analyzed retrospectively. Prostate specific antigen, prostate volume, IPSS, NIH-CPSI, international index of erectile function (IIEF-5), and uroflowmetry were collected. Patients were categorized according to 2 groups based on the presence and severity of pain and baseline characteristics and treatment outcomes were analyzed.
Results: Two hundred twenty-nine patients (64.3%) reported pain/discomfort on NIH-CPSI. Mean IPSS, mean voiding symptoms, mean storage symptoms on IPSS, and mean IIEF-5 showed a significant difference in groups 1A and 1B. Logistic regression analysis showed that NIH-CPSI pain score was a significant predictive factor for severe IPSS (odds ratio, 2.830; 95% confidence interval, 1.307-6.129). After treatment for 3 months, improvement of IPSS, voiding symptoms, storage symptoms, and quality of life was observed in all groups (p=0.001, p<0.001, p=0.026, p<0.001, p<0.001, p<0.001, p<0.001, p<0.001). Group 2B (pain score>5) showed greater improvement of symptoms and statistically significant difference compared with group 2A (pain score ≤5) (p=0.029, p=0.026).
Conclusions: We suggest that the presence and severity of pain score are helpful for therapeutic efficacy in patients with BPH.
-
Penile Mass Caused by Mycobacterium tuberculosis
-
Seung Hoon Ryang, Minseob Eom, Tae Wook Kang, Chang Min Lee, Hyun Chul Chung, Jae Mann Song, Kwang Jin Kim, Jae Hung Jung
-
Urogenit Tract Infect 2015;10(2):126-129. Published online October 31, 2015
-
-
-
Abstract
PDF
- Tuberculosis of the penis is rare. The clinical features of penile tuberculosis are usually manifested as ulceration or scars. However, the authors encountered a case of penile tuberculosis that presented as a mass. A painless nodule at the base of the penis was noted in a 63-year-old male patient. Surgical excision was recommended, and pathologic finding revealed granulomatous inflammation in the mass. Acid fast bacilli stain and culture were negative, but a positive result was found in urine polymerase chain reaction for detection of Mycobacterium tuberculosis. He was diagnosed with tuberculosis of the penis and underwent anti-tuberculosis chemotherapy.
|
KAUTI
